5-HT2C agonist (Kuleon)

N/A

Report date: 2025/01/26 19:03:11
NME

Base Information

Drug Name5-HT2C agonist (Kuleon)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonistsSerotonin 2c (5-HT2c) receptor agonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptorSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsDementia-related PsychosisSchizophreniaObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKüleon LLC
China Registration ClassN/A

Develop Information

Active CompaniesKüleon LLC
Inactive CompaniesN/A
Active IndicationsDementia-related PsychosisSchizophreniaObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A